1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Czech Republic >
  5. Ergomed Acquires European PharmInvent Services s.r.o.

M&A Deal Summary

Ergomed Acquires European PharmInvent Services s.r.o.

On November 29, 2016, Ergomed acquired healthcare services company European PharmInvent Services s.r.o. for 5M EUR

Acquisition Highlights
  • This is Ergomed’s 1st transaction in the Healthcare Services sector.
  • This is Ergomed’s 6th largest (disclosed) transaction.
  • This is Ergomed’s 1st transaction in Czech Republic.

M&A Deal Summary
Date 2016-11-29
Target European PharmInvent Services s.r.o.
Sector Healthcare Services
Buyer(s) Ergomed
Deal Type Add-on Acquisition
Deal Value 5M EUR

Target

European PharmInvent Services s.r.o.

Prague, Czech Republic
European PharmInvent Services s.r.o. is a European pharmacovigilance and regulatory services business. PharmInvent offers a comprehensive range of pharmacovigilance and regulatory services to over 100 clients in the global pharmaceutical industry. Led by a team of highly experienced and qualified medical doctors and pharmacists, pharmacovigilance services include an outsourced global network of 95 Qualified Persons for Pharmacovigilance (QPPVs) in 50 countries, case management, risk management, audit, training and consulting services on the establishment and maintenance of pharmacovigilance systems. Regulatory services include strategic advice on regulatory strategy, clinical trial and protocol design and medical writing of regulatory submissions. PharmInvent's highly qualified workforce of 60 people includes 10 medical doctors, 28 pharmacists and 16 scientists with advanced degrees.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Ergomed

Guildford, United Kingdom
Category Company
Founded 1997
Sector Life Science
Employees1,371
Revenue 119M GBP (2021)
DESCRIPTION

Ergomed is a profitable UK-based business providing drug development services to the pharmaceutical industry and has a growing portfolio of co-development partnerships. It operates in over 50 countries. Ergomed provides clinical development, trial management and pharmacovigilance services to over 100 clients ranging from top 10 pharmaceutical companies to small and mid-sized drug development companies. Ergomed was founded in 1997 and is based in Guildford, United Kingdom.

DEAL STATS #
Overall 4 of 8
Sector: Healthcare Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 4 of 7
Country: Czech Republic M&A 1 of 1
Year: 2016 M&A 4 of 4
Size (of disclosed) 6 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-06-13 Dr. Oestreich und Partner

Cologne, Germany

Dr. Oestreich und Partner GmbH is a full service contract research organisation offer comprehensive, complete or individual solutions for clinical studies in the pharmaceutical area (phase II to IV as well as PASS, PAES, NIS, proof of additional benefit, economy studies) for more than 20 years. Company also conduct literature research, perform clinical studies and handle tasks in Regulatory Affairs for Medical Devices with the aim of CE-marking, first registration in the market and keeping your product on the market.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-09-28 PSR Group B.V.

Hoofddorp, Netherlands

PSR Group B.V. is a full service specialist orphan drug CRO and recognised as a leading expert in the rare disease niche. PSR specialises in running complex orphan drug development programs requiring innovative regulatory and clinical approaches as well as pricing and reimbursement strategies. Besides outsourced project solutions, PSR provides insourced staffing solutions (orphan drug teams), temporary & permanent staffing, interim management solutions as well as training / coaching career programs.

Buy €6M
Mergr

Solution for

Product

Company

Legal